TEVADAPTOR® IS CONTINUING TO EXPAND GLOBALLY!
We are looking for partners and distributors worldwide to grow with us!
Tevadaptor® is a closed system transfer device (CSTD) for safe compounding and administration. It minimizes the risk of exposure to hazardous drugs, such as those found in Oncology, alongside maintaining drug sterility and eliminating the risk of needle-stick injuries, keeping pharmacists, nurses and patients safe.
We are pleased to announce that as of May 1st SIMPLIVIA Healthcare LTD. incorporates the Tevadaptor® global business and manufacturing activity.
Tevadaptor® is a profitable global medical device business, which was founded in 2005 and is currently selling in more than 25 countries. With presence in world leading markets, such as US, Japan, large EU markets and more, Tevadaptor® continues to expand to new markets worldwide.
The company was acquired by Fimi opportunity fund – one of the top 5 investment funds in the world in terms of consistency of performance.
Tevadaptor® has a CE mark and is FDA cleared under the ONB product code, meeting NIOSH CSTD definitions – a Closed System Transfer Device that mechanically prohibits the release of the drug in vapor, aerosol or liquid form during preparation and administration.
Tevadaptor® is manufactured with the highest quality standards (MDD, EN ISO 13485, FDA and JP regulation).
Tevadaptor® is easy to use and intuitive. This, together with a low number of SKU’s, which cover all product applications, make it user friendly, compliant and easy to store and manage.